全文获取类型
收费全文 | 166081篇 |
免费 | 13787篇 |
国内免费 | 5031篇 |
专业分类
耳鼻咽喉 | 1175篇 |
儿科学 | 3255篇 |
妇产科学 | 1721篇 |
基础医学 | 24426篇 |
口腔科学 | 3215篇 |
临床医学 | 16834篇 |
内科学 | 23638篇 |
皮肤病学 | 1759篇 |
神经病学 | 8001篇 |
特种医学 | 3984篇 |
外国民族医学 | 24篇 |
外科学 | 14021篇 |
综合类 | 25294篇 |
现状与发展 | 11篇 |
一般理论 | 25篇 |
预防医学 | 12233篇 |
眼科学 | 4590篇 |
药学 | 17484篇 |
15篇 | |
中国医学 | 8093篇 |
肿瘤学 | 15101篇 |
出版年
2024年 | 129篇 |
2023年 | 2346篇 |
2022年 | 3439篇 |
2021年 | 6338篇 |
2020年 | 5773篇 |
2019年 | 6253篇 |
2018年 | 5988篇 |
2017年 | 5477篇 |
2016年 | 5324篇 |
2015年 | 5396篇 |
2014年 | 8881篇 |
2013年 | 9607篇 |
2012年 | 7888篇 |
2011年 | 9143篇 |
2010年 | 7894篇 |
2009年 | 7773篇 |
2008年 | 7906篇 |
2007年 | 8936篇 |
2006年 | 8102篇 |
2005年 | 8073篇 |
2004年 | 7039篇 |
2003年 | 6244篇 |
2002年 | 4612篇 |
2001年 | 4525篇 |
2000年 | 3695篇 |
1999年 | 3395篇 |
1998年 | 2315篇 |
1997年 | 2071篇 |
1996年 | 2188篇 |
1995年 | 2195篇 |
1994年 | 1917篇 |
1993年 | 1754篇 |
1992年 | 1527篇 |
1991年 | 1314篇 |
1990年 | 1117篇 |
1989年 | 1049篇 |
1988年 | 992篇 |
1987年 | 747篇 |
1986年 | 570篇 |
1985年 | 684篇 |
1984年 | 710篇 |
1983年 | 438篇 |
1982年 | 542篇 |
1981年 | 456篇 |
1980年 | 404篇 |
1979年 | 335篇 |
1978年 | 270篇 |
1977年 | 225篇 |
1976年 | 248篇 |
1975年 | 156篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
41.
42.
Weina Cheng Yazhi Wang Jingxian Liu Xiaofei Li Ming Yu Cancan Duan Liu Liu Jianyong Zhang 《Journal of applied toxicology : JAT》2022,42(6):970-980
Cantharidin (CTD) is an effective antitumor agent. However, it exhibits significant hepatotoxicity, the mechanism of which remains unclear. In this study, biochemical and histopathological analyses complemented with ultra-high-performance liquid chromatography–tandem mass spectrometry (UHPLC-MS/MS)-based targeted metabolomic analysis of bile acids (BAs) were employed to investigate CTD-induced hepatotoxicity in rats. Sixteen male and female Sprague–Dawley rats were randomly divided into two groups: control and CTD (1.0 mg/kg) groups. Serum and liver samples were collected after 28 days of intervention. Biochemical, histopathological, and BA metabolomic analyses were performed for all samples. Further, the key biomarkers of CTD-induced hepatotoxicity were identified via multivariate and metabolic pathway analyses. In addition, metabolite–gene–enzyme network and Kyoto Encyclopedia of Genes and Genomes pathway analyses were used to identify the signaling pathways related to CTD-induced hepatotoxicity. The results revealed significantly increased levels of biochemical indices (alanine aminotransferase, aspartate aminotransferase, and total bile acid). Histopathological analysis revealed that the hepatocytes were damaged. Further, 20 endogenous BAs were quantitated via UHPLC-MS/MS, and multivariate and metabolic pathway analyses of BAs revealed that hyocholic acid, cholic acid, and chenodeoxycholic acid were the key biomarkers of CTD-induced hepatotoxicity. Meanwhile, primary and secondary BA biosynthesis and taurine and hypotaurine metabolism were found to be associated with the mechanism by which CTD induced hepatotoxicity in rats. This study provides useful insights for research on the mechanism of CTD-induced hepatotoxicity. 相似文献
43.
《Journal of vascular and interventional radiology : JVIR》2022,33(8):964-971.e2
PurposeTo assess the cost effectiveness of microwave ablation (MWA) and stereotactic body radiotherapy (SBRT) for patients with inoperable stage I non–small cell lung cancer (NSCLC).Materials and MethodsA literature search was performed in MEDLINE with broad search clusters. A decision-analytic model was constructed over a 5-year period. The model incorporated treatment-related complications and long-term recurrence. All clinical parameters were derived from the literature with preference to long-term prospective trials. A healthcare payers’ perspective was adopted. Outcomes were measured in quality-adjusted life years (QALYs) extracted from prior studies and U.S. dollars from Medicare reimbursements and prior studies. Base case calculations, probabilistic sensitivity analysis with 10,000 Monte Carlo simulations, and multiple 1- and 2-way sensitivity analyses were performed.ResultsMWA yielded a health benefit of 2.31 QALYs at a cost of $195,331, whereas SBRT yielded a health benefit of 2.33 QALYs at a cost of $225,271. The incremental cost-effectiveness ratio was $1,480,597/QALY, indicating that MWA is the more cost-effective strategy. The conclusion remains unchanged in probabilistic sensitivity analysis with MWA being the optimal cost strategy in 99.84% simulations. One-way sensitivity analyses revealed that MWA remains cost effective when its annual recurrence risk is <18.4% averaged over 5 years, when the SBRT annual recurrence risk is >1.44% averaged over 5 years, or when MWA is at least $7,500 cheaper than SBRT.ConclusionsMWA appears to be more cost effective than SBRT for patients with inoperable stage I NSCLC. 相似文献
44.
45.
46.
Stephanie H. Ameis John D. Haltigan Rachael E. Lyon Amanda Sawyer Pat Mirenda Connor M. Kerns Isabel M. Smith Tracy Vaillancourt Joanne Volden Charlotte Waddell Lonnie Zwaigenbaum Teresa Bennett Eric Duku Mayada Elsabbagh Stelios Georgiades Wendy J. Ungar Anat Zaidman-Zait Meng-Chuan Lai Peter Szatmari for the Pathways in ASD Study Team 《Journal of child psychology and psychiatry, and allied disciplines》2022,63(5):553-562
47.
《Saudi Dental Journal》2022,34(7):596-603
ObjectiveStudies have shown that gingival crevices may be a significant route for SARS-CoV-2 entry. However, the role of oral health in the acquisition and severity of COVID-19 is not known.DesignA retrospective analysis was performed using electronic health record data from a large urban academic medical center between 12/1/2019 and 8/24/2020. A total of 387 COVID-19 positive cases were identified and matched 1:1 by age, sex, and race to 387 controls without COVID-19 diagnoses. Demographics, number of missing teeth and alveolar crestal height were determined from radiographs and medical/dental charts. In a subgroup of 107 cases and controls, we also examined the rate of change in alveolar crestal height. A conditional logistic regression model was utilized to assess association between alveolar crestal height and missing teeth with COVID-19 status and with hospitalization status among COVID-19 cases.ResultsIncreased alveolar bone loss, OR = 4.302 (2.510 – 7.376), fewer missing teeth, OR = 0.897 (0.835–0.965) and lack of smoking history distinguished COVID-19 cases from controls. After adjusting for time between examinations, cases with COVID-19 had greater alveolar bone loss compared to controls (0.641 ± 0.613 mm vs 0.260 ± 0.631 mm, p < 0.01.) Among cases with COVID-19, increased number of missing teeth OR = 2.1871 (1.146– 4.174) was significantly associated with hospitalization.ConclusionsAlveolar bone loss and missing teeth are positively associated with the acquisition and severity of COVID-19 disease, respectively. 相似文献
48.
Hendrik Kröning Thomas Göhler Thomas Decker Marc Grundeis Georgi Kojouharoff Jörg Lipke Dieter Semsek Enno Moorahrend Annette Sauer Harald-Robert Bruch Rüdiger Liersch Arnd Nusch Ursula Vehling-Kaiser Manfred Welslau Ralf Grunewald Hanns-Detlev Harich Marcel Stephany Jens Uhlig Rebecca de Buhr Melanie Frank Cathrin Hogrefe Norbert Marschner Karin Potthoff Frank Hartmann Timo Reisländer Ingo Schwaner 《International journal of cancer. Journal international du cancer》2023,153(6):1227-1240
The prospective, multicenter, noninterventional TACTIC study assessed effectiveness and safety of trifluridine/tipiracil (FTD/TPI) in patients with metastatic colorectal cancer (mCRC) in a real-world setting in Germany, thus evaluating the external validity of the findings from the pivotal RECOURSE trial. Primary endpoint was overall survival (OS). Secondary objectives included progression-free survival (PFS), safety, and quality of life (QoL). Subgroups comprised patients with good (<3 metastatic sites at inclusion, ≥18 months from diagnosis of first metastasis to inclusion) or poor (remaining patients) prognostic characteristics (GPC/PPC). GPC without liver metastases was considered best prognostic characteristics (BPC). In total, 307 eligible patients (pretreated or not suitable for other available therapies) were treated with FTD/TPI. Overall, median [95%-CI] OS was 7.4 months [6.4-8.6], median PFS was 2.9 months [2.8-3.3]. In BPC (n = 65) and GPC (n = 176) compared to PPC (n = 124) subgroup, median OS (13.3 [9.1-17.6] vs 8.9 [7.6-9.8] vs 5.1 [4.4-7.0] months) and median PFS (4.0 [3.3-5.3] vs 3.4 [3.0-3.7] vs 2.6 [2.4-2.8] months) were longer. Patient-reported QoL, assessed by validated questionnaires (EQ-5D-5L, PRO-CTCAE), was stable throughout FTD/TPI treatment. Predominant FTD/TPI-related adverse events of grades 3 or 4 were neutropenia (13.0%), leukopenia (7.5%), and anemia (5.2%). Altogether, palliative FTD/TPI therapy in patients with pretreated mCRC was associated with prolonged survival, delayed progression, maintained health-related QoL, and manageable toxicity. Low metastatic burden and indolent disease were favorable prognostic factors for survival. TACTIC confirms the effectiveness and safety of FTD/TPI, highlighting its value in routine clinical practice. 相似文献
49.
Loren Saulsberry PhD Ankur Bhargava MD MPH Sharon Zeng BA Jason B. Gibbons PhD Cody Brannan MS Diane S. Lauderdale PhD Robert D. Gibbons PhD 《Health services research》2023,58(4):873-881
Objective
To derive and validate a new ecological measure of the social determinants of health (SDoH), calculable at the zip code or county level.Data Sources and Study Setting
The most recent releases of secondary, publicly available data were collected from national U.S. health agencies as well as state and city public health departments.Study Design
The Social Vulnerability Metric (SVM) was constructed from U.S. zip-code level measures (2018) from survey data using multidimensional Item Response Theory and validated using outcomes including all-cause mortality (2016), COVID-19 vaccination (2021), and emergency department visits for asthma (2018). The SVM was also compared with the existing Centers for Disease Control and Prevention's Social Vulnerability Index (SVI) to determine convergent validity and differential predictive validity.Data Collection/Extraction Methods
The data were collected directly from published files available to the public online from national U.S. health agencies as well as state and city public health departments.Principal Findings
The correlation between SVM scores and national age-adjusted county all-cause mortality was r = 0.68. This correlation demonstrated the SVM's robust validity and outperformed the SVI with an almost four-fold increase in explained variance (46% vs. 12%). The SVM was also highly correlated (r ≥ 0.60) to zip-code level health outcomes for the state of California and city of Chicago.Conclusions
The SVM offers a measurement tool improving upon the performance of existing SDoH composite measures and has broad applicability to public health that may help in directing future policies and interventions. The SVM provides a single measure of SDoH that better quantifies associations with health outcomes. 相似文献50.
背景 随着血糖监测技术的发展,近些年来人们开始使用扫描式葡萄糖监测系统(FGMS)"全景式"地观察2型糖尿病(T2DM)患者的血糖水平,明确FGMS指标与T2DM并发症之间的关系有助于提高其临床应用价值,但目前相关研究较少。 目的 探究佩戴FGMS的T2DM患者葡萄糖在目标范围内时间(TIR)等指标与尿白蛋白/肌酐比值(UACR)的相关性。 方法 选取2019年1月至2021年10月于北京大学人民医院老年科就诊并佩戴FGMS的T2DM患者79例,以尿液检查中UACR是否<30 mg/g将患者分为无白蛋白尿组(n=50)和白蛋白尿组(n=29)。比较两组患者的临床特征、实验室检查指标及FGMS指标等。采用Pearson相关、Spearman秩相关分析探讨TIR、高血糖时间(TAR)与糖化血红蛋白(HbA1c)的相关性。分别采用Pearson相关、Spearman秩相关、偏相关分析探讨FGMS指标与lnUACR的相关性。使用多因素Logistic回归分析探究T2DM患者发生白蛋白尿的影响因素,采用受试者工作特征(ROC)曲线评估TIR对白蛋白尿的预测价值。 结果 白蛋白尿组T2DM病程长于无白蛋白尿组,三酰甘油(TG)、HbA1c、平均血糖(MBG)、TAR、平均血糖标准差(SDBG)、最大葡萄糖波动幅度(LAGE)、平均葡萄糖波动幅度(MAGE)、连续每隔2 h血糖净作用(CONGA2)高于无白蛋白尿组,TIR低于无白蛋白尿组(P<0.05)。Pearson相关、Spearman秩相关分析结果显示,TIR与HbA1c呈负相关(P<0.001),TAR与HbA1c呈正相关(P<0.001)。Pearson相关、Spearman秩相关、偏相关分析结果均表明,TIR与lnUACR呈负相关(P<0.001),MBG、TAR、SDBG、LAGE、MAGE、CONGA2与lnUACR呈正相关(P<0.001)。多因素Logistic回归分析结果显示,TIR>70%〔OR=0.038,95%CI(0.003,0.467)〕是T2DM患者出现白蛋白尿的保护因素(P<0.05),TAR升高〔OR=1.046,95%CI(1.000,1.094)〕是T2DM患者出现白蛋白尿的危险因素(P<0.05)。TIR预测T2DM患者出现白蛋白尿的ROC曲线下面积(AUC)为0.784〔95%CI(0.674,0.894)〕(P=0.003),灵敏度为78%,特异度为83%,最佳切点为69.71%。 结论 在FGMS指标中,TIR>70%是T2DM患者出现白蛋白尿的保护因素,TAR升高是T2DM患者出现白蛋白尿的危险因素。同时,SDBG、LAGE、MAGE、CONGA2等多种反映血糖波动的指标也与UACR密切相关。对TIR水平较低及TAR、SDBG、LAGE、MAGE、CONGA2水平较高的T2DM患者进行FGMS筛查有助于早期识别及预防白蛋白尿的发生、发展。 相似文献